查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018715

短读定序市场：依产品、技术、最终用户和应用划分－2026-2032年全球市场预测

Short-read Sequencing Market by Product, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，短读定序市场价值将达到 78.4 亿美元，到 2026 年将成长到 91.5 亿美元，到 2032 年将达到 227.6 亿美元，年复合成长率为 16.42%。

主要市场统计数据
基准年 2025 78.4亿美元
预计年份：2026年 91.5亿美元
预测年份 2032 227.6亿美元
复合年增长率 (%) 16.42%

策略性应用凸显了短读定定序在调查、诊断和商业应用中的操作和科学重要性。

短读长定序已从一项创新的实验室技术发展成为现代分子生物学、临床诊断和工业生物技术的基础能力。化学、仪器和数据处理技术的进步提高了其容量、准确性和成本效益，使其能够在所有研究、临床和商业环境中进行常规应用。因此，从学术实验室到大型製药企业，相关人员都在重新思考工作流程、合作模式和资金分配，以便将定序驱动的洞见融入其核心营运中。

快速的技术进步、软体的普及以及不断演变的服务模式如何改变短读定序的采用和价值交付。

短读长定序领域正经历着一场变革性的转变，这主要由技术、监管和市场因素共同驱动。化学和仪器技术的进步不断提高读取准确率，降低批间差异，并简化样本製备流程，所有这些改进共同降低了分散式环境中应用该技术的门槛。同时，样品製备盒和流动池设计的进步缩短了结果获取时间，实现了临床工作流程的快速週转，并强化了定序在时间紧迫的诊断中的作用。

本研究评估了 2025 年美国关税变化将如何影响整个定序生态系统的供应链韧性、采购定序和筹资策略。

美国2025年实施的新关税和贸易措施，对依赖进口试剂、耗材和设备的企业而言，在合规性和成本管理方面提出了严峻挑战。这些政策变化迫使采购团队和供应商重新思考筹资策略，探索替代物流路线，并评估近岸外包和区域经销伙伴，以减轻关税相关价格波动的影响。随着企业不断调整，他们越来越重视合约柔软性、供应商多元化和库存管理，以维持业务永续营运。

整合细分洞察，揭示产品类型、定序技术、使用者画像和应用模式如何共同塑造采用趋势和价值链。

要了解市场动态，必须清楚掌握产品、技术、终端用户和应用如何交织并塑造需求和采用模式。基于产品，市场可细分为耗材、仪器以及软体和服务。耗材又可细分为流动池、试剂和样品製备盒；仪器可细分为桌上型定序仪和高通量定序仪；软体和服务可细分为生物资讯服务和资料分析软体。从这个产品层面的架构可以看出，流程依赖性和试剂的持续消耗驱动着持续的收入模式，而仪器资本投资决策则受到处理能力、面积和整合功能的影响。

区域趋势和政策环境解释了美洲、欧洲、中东和非洲以及亚太市场在采用通路和供应商策略方面的差异。

区域趋势在短读长定序的应用、监管核准和商业化策略中发挥核心作用。在美洲，完善的研究基础设施、广泛的临床试验网络以及相对成熟的报销机制，为定序在诊断和治疗方法发现领域的快速应用提供了支持。生物技术中心和大型定序中心的集中，催生了对高通量设备和先进生物资讯学服务的需求。同时，采购惯例也更重视服务水准保证和与供应商建立长期伙伴关係。

主要企业如何将设备创新、耗材可靠性和分析服务结合，以建立整合平台和持久的客户关係？

处于短读长定序领域前沿的公司正透过整合平台功能、拓展服务范围以及建立策略伙伴关係关係来加速临床部署，从而实现差异化竞争优势。领先的仪器製造商不断提升通量、运作和自动化能力，而试剂和耗材製造商则专注于批间一致性、供应链透明度和精简的工作流程，以减少对操作人员的依赖。提供检验的流程、可解读的报告和安全资料管理的软体和服务供应商正变得至关重要，尤其是在临床和监管应用场景中。

产业领袖提出切实可行的建议，以增强供应链韧性、以客户为中心的服务交付和临床检验流程，从而促进永续部署。

产业领导者应优先考虑兼顾短期业务永续营运和长期策略定位的措施。首先，加强供应链多元化并建立区域製造或经销伙伴关係，可以提高服务应对力，同时降低关税和物流波动风险。其次，投资检体、使用者友善的工作流程，涵盖样品製备、分析自动化和检验分析，可以降低临床和分散式研究环境中采用这些流程的门槛，并加快获得结果的速度。

高度透明的调查方法结合了第一手访谈、二手资讯检验和交叉細項分析，确保了可靠且可操作的见解。

本分析所依据的研究融合了定性和定量方法，以确保得出可靠且可重复的结论。主要研究包括对学术机构、临床机构和商业机构的高阶主管、实验室经理、采购经理和技术专家进行结构化访谈。这些访谈提供了关于技术采纳驱动因素、检验要求、采购行为和营运挑战的第一手观点，为主题整合和情境分析奠定了基础。

结论是：整合技术成熟度、营运韧性和协作策略，以实现短读定序的价值。

总之，短读长定序正处于成熟技术能力和不断扩展的应用范围的交汇点，在准确性、通量和成熟的分析生态系统之间实现了切实可行的平衡。试剂、仪器自动化和数据分析技术的持续改进正将其应用范围从核心实验室扩展到临床和工业领域。同时，不断变化的法规和关税导致的供应链调整等外部因素正促使相关人员采取更具韧性的采购和检验措施。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 短读定序市场：依产品划分

  • 消耗品
    • 流动池和试剂
    • 样品製备工具包
  • 装置
    • 桌上型音序器
    • 高通量定序仪
  • 软体服务
    • 生物资讯服务
    • 数据分析软体

第九章 短读定序市场：依技术分类

  • 半导体定序
    • Ion Proton
    • Ion Torrent PGM
  • 接合性定序
  • 定序合成

第十章：短读定序市场：依最终用户划分

  • 学术和研究机构
  • 合约研究机构
  • 医院/诊断检查室
  • 製药和生物技术公司

第十一章 短读定序市场：依应用领域划分

  • 表观基因
    • 染色质可及性分析
    • DNA甲基化分析
  • 基因组学
    • 重测序
    • 目标序列
    • 全基因组定序
  • 总体基因体学
  • 转录组学

第十二章 短读定序市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 短读定序市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 短读定序市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国短读定序市场

第十六章：中国短序列定序市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eppendorf SE
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare Technologies Inc.
  • Genewiz, Inc.
  • Hamilton Company
  • Illumina, Inc.
  • Macrogen, Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Psomagen, Inc.
  • Qiagen NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AD36CD898498

The Short-read Sequencing Market was valued at USD 7.84 billion in 2025 and is projected to grow to USD 9.15 billion in 2026, with a CAGR of 16.42%, reaching USD 22.76 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.84 billion
Estimated Year [2026] USD 9.15 billion
Forecast Year [2032] USD 22.76 billion
CAGR (%) 16.42%

A strategic introduction highlighting the operational and scientific relevance of short-read sequencing across research, diagnostics, and commercial applications

Short-read sequencing has matured from a disruptive laboratory technique into a foundational capability that underpins modern molecular biology, clinical diagnostics, and industrial biotechnology. Advances in chemistry, instrumentation, and data processing have pushed throughput, accuracy, and cost-efficiency to levels that enable routine deployment across research, clinical, and commercial environments. As a result, stakeholders ranging from academic laboratories to large pharmaceutical companies are rethinking workflows, partnering models, and capital allocation to integrate sequencing-driven insights into core operations.

This introduction frames the strategic importance of short-read platforms by linking recent technological improvements to practical outcomes. Short-read approaches continue to offer high per-base accuracy, established bioinformatics ecosystems, and relative affordability for targeted and whole-genome assays. Consequently, they remain the preferred option for many standard applications even as long-read technologies gain traction in niche areas. Throughout this document, we adopt a lens that balances technical nuance with operational relevance, emphasizing how iterative improvements in reagents, instrumentation, and analytics combine to reshape decision-making horizons.

Through this perspective, readers will gain an understanding of where short-read sequencing delivers the greatest incremental value, how adoption patterns differ by user profile, and which strategic responses are most effective for organizations seeking to leverage sequencing as a competitive advantage. The following sections unpack the transformative shifts, policy impacts, segmentation logic, regional distinctions, leading corporate behaviors, actionable recommendations, and the research methodology that together support robust decision-making.

How rapid technological refinements, software democratization, and evolving service models are reshaping short-read sequencing adoption and value delivery

The landscape of short-read sequencing is experiencing transformative shifts driven by converging technological, regulatory, and market forces. Chemistry and instrument refinements have steadily improved read accuracy, reduced run-to-run variability, and simplified sample preparation, which collectively lower barriers to adoption in decentralized settings. Parallel advances in library preparation kits and flow cell design have shortened time-to-answer and enabled faster turnaround in clinical workflows, reinforcing sequencing's role in time-sensitive diagnostics.

At the same time, software innovations and cloud-native bioinformatics pipelines are democratizing access to advanced analysis, allowing smaller laboratories to apply complex variant calling, transcript quantification, and metagenomic profiling. Interoperability and standardized data formats are facilitating collaborative research and multi-center studies. Meanwhile, the competitive dynamic among instrument and reagent providers is accelerating product development cycles and expanding service offerings such as integrated sample-to-insight platforms.

Regulatory and reimbursement environments are also evolving; stricter validation requirements coexist with clearer pathways for diagnostic approval, which incentivizes vendors to invest in robust clinical utilities. Supply chain optimization and modular business models, including instrument-as-a-service and reagent subscriptions, are reshaping customer relationships. In short, the short-read sequencing ecosystem is shifting toward greater accessibility, higher integration, and more diverse commercialization models that collectively broaden its impact across scientific and clinical domains.

Assessing how United States tariff changes for 2025 are driving supply chain resilience, sourcing shifts, and procurement strategies across the sequencing ecosystem

The imposition of new tariffs and trade measures in the United States for 2025 has introduced a material compliance and cost-management dimension for organizations that rely on imported reagents, consumables, and instrumentation. These policy changes have prompted procurement teams and suppliers to reassess sourcing strategies, consider alternative logistics pathways, and evaluate nearshoring or regional distribution partnerships to mitigate exposure to tariff-driven price variability. As companies adjust, they increasingly emphasize contractual flexibility, multi-supplier qualification, and inventory management to sustain operational continuity.

In response to tariff pressures, some manufacturers have accelerated localization of production for high-volume consumables and critical components, while service providers have explored value-added logistics solutions to shield end users from sudden cost shifts. Regulatory scrutiny of supply chains has also risen, prompting enhanced documentation, supplier audits, and traceability measures that extend the timeline and complexity of vendor qualification processes. Consequently, capital planning cycles for laboratories and clinical adopters now account for potential tariff-related schedule and cost deviations.

Looking forward, the tariffs have catalyzed broader conversations about supply chain resilience, procurement governance, and strategic inventory posture. Organizations that proactively diversify supplier bases, engage in forward purchasing where appropriate, and collaborate with vendors on localized production and consignment models are better positioned to maintain consistent access to sequencing reagents and instruments while preserving budget predictability.

Integrated segmentation insights revealing how product types, sequencing technologies, user profiles, and application modalities together shape adoption and value chains

Understanding market dynamics requires a clear view of how products, technologies, end users, and applications intersect to shape demand and adoption patterns. Based on product, the market is examined across Consumables, Instruments, and Software & Services with Consumables further segmented into Flow Cells & Reagents and Library Prep Kits, Instruments separated into Benchtop Sequencers and High-Throughput Sequencers, and Software & Services divided into Bioinformatics Services and Data Analysis Software. This product-level framing reveals that procedural dependencies and recurring reagent consumption drive recurring revenue models, while instrument capital expenditure decisions hinge on throughput, footprint, and integration capability.

Based on technology, the landscape is charted across Semiconductor Sequencing, Sequencing Ligation, and Sequencing Synthesis, with Semiconductor Sequencing further characterized by platforms such as Ion Proton and Ion Torrent PGM. Each technology presents distinct trade-offs in read length, throughput, and run economics, which influence suitability for specific applications. Based on end user, the market encompasses Academic & Research Institutes, Contract Research Organizations, Hospitals & Diagnostic Labs, and Pharma & Biotech Companies, and this segmentation clarifies how purchasing cycles, validation demands, and service expectations vary across institutions.

Based on application, the analysis addresses Epigenomics, Genomics, Metagenomics, and Transcriptomics, further detailing Epigenomics into Chromatin Accessibility Analysis and DNA Methylation Analysis, and Genomics into Resequencing, Targeted Sequencing, and Whole Genome Sequencing. This application-focused perspective underscores how analytical priorities-such as depth versus breadth of coverage, sensitivity for rare variants, and throughput-determine the optimal constellation of products and services for a given use case. Integrating these segmentation lenses enables more precise market positioning, technology roadmapping, and customer engagement strategies.

Regional dynamics and policy environments explain distinct adoption pathways and vendor strategies across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics play a central role in shaping the deployment, regulatory acceptance, and commercial strategies for short-read sequencing. In the Americas, robust research infrastructure, wide availability of clinical trial networks, and relatively mature reimbursement pathways support rapid translation of sequencing into diagnostics and therapeutics discovery. The concentration of biotech hubs and large-scale sequencing centers creates demand for both high-throughput instruments and sophisticated bioinformatics services, while procurement practices emphasize service-level guarantees and long-term vendor partnerships.

In Europe, Middle East & Africa, regulatory diversity and varying levels of infrastructure investment create a heterogeneous adoption landscape. Western European markets often prioritize hospital integration and clinical validation pathways, whereas emerging markets in the region show strong academic research uptake and increasing interest from public health programs. Strategic partnerships that include training, local technical support, and adaptive pricing models accelerate broader adoption across these varied contexts. Regulatory harmonization efforts and cross-border research consortia are progressively smoothing integration challenges.

In Asia-Pacific, rapid capacity building, government-supported genomics initiatives, and strong manufacturing capabilities are accelerating both demand and local supply. High-throughput sequencing applications tied to population-scale studies and genomics-driven drug discovery are prominent, and regional providers are increasingly competitive on cost, localization, and scale. Across all regions, geographic considerations inform choices about inventory buffers, training programs, and deployment models, and vendors that tailor offerings to regional needs and policy environments gain a strategic advantage.

How leading companies combine instrument innovation, consumable reliability, and analytics services to build integrated platforms and durable customer relationships

Companies at the forefront of short-read sequencing are differentiating through integrated platform capabilities, expanded service offerings, and strategic partnerships that accelerate clinical adoption. Leading instrument manufacturers continue to iterate on throughput, run-time, and automation features, while reagent and consumable producers focus on lot-to-lot consistency, supply chain transparency, and streamlined workflows that reduce operator dependency. Service and software providers that deliver validated pipelines, interpretive reporting, and secure data management are becoming indispensable, especially for clinical and regulatory use cases.

Competitive positioning now extends beyond hardware to include recurring revenue models, cloud-enabled analytics, and co-development arrangements with large academic centers and pharmaceutical customers. As a result, some vendors are bifurcating their business models to serve high-throughput central laboratories while offering simplified benchtop solutions for point-of-care and smaller research settings. Partnerships with contract research organizations and localized distribution networks help many companies scale internationally while maintaining compliance and technical support standards.

Strategic acquisitions, collaborative development agreements, and investments in manufacturing redundancy are common tactics companies use to secure supply continuity and broaden technological portfolios. Firms that emphasize interoperability, open data standards, and comprehensive customer education programs earn greater trust among institutional buyers and clinical laboratories, which in turn supports deeper long-term relationships and recurring business.

Actionable recommendations for industry leaders to enhance supply resilience, customer-centric offerings, and clinical validation pathways that drive sustained adoption

Industry leaders should prioritize actions that balance near-term operational resilience with long-term strategic positioning. First, strengthening supply chain diversity and establishing regional manufacturing or distribution partnerships will reduce exposure to tariff and logistics volatility while improving service responsiveness. Second, investing in validated, user-friendly workflows-spanning sample prep, run automation, and standardized analytics-will lower the barrier to adoption across clinical and decentralized research settings and accelerate time-to-impact.

Third, building modular business models that offer both capital acquisition and subscription-based reagent or software services creates more predictable revenue streams and aligns vendor incentives with customer success. Fourth, companies should deepen collaborations with clinical networks and regulatory bodies to co-develop validation datasets and diagnostic use cases, thereby reducing time-to-market for clinical assays. Fifth, focusing on data interoperability, privacy-compliant cloud frameworks, and interpretive reporting will make sequencing outputs actionable for clinicians and researchers alike.

Finally, leaders must invest in workforce enablement through training, certification, and localized technical support to ensure customers achieve consistent, high-quality results. By combining operational robustness with customer-centric product development and collaborative validation pathways, organizations can capture greater strategic value from the expanding role of short-read sequencing in science and medicine.

Transparent research methodology combining primary interviews, secondary source triangulation, and cross-segmentation analysis to ensure reliable and actionable insights

The research underpinning this analysis integrates qualitative and quantitative approaches to ensure robust, reproducible insights. Primary research included structured interviews with executives, laboratory directors, procurement leads, and technical specialists across academic, clinical, and commercial institutions. These interviews provided firsthand perspectives on adoption drivers, validation requirements, procurement behaviors, and operational pain points, which informed thematic synthesis and scenario analysis.

Secondary research encompassed peer-reviewed literature, regulatory guidance documents, company technical specifications, white papers, and public disclosures that describe technological capabilities, workflow performance metrics, and deployment case studies. Comparative evaluation of these sources enabled triangulation of product characteristics, application suitability, and commercial strategies. Where appropriate, supplier documentation and open data repositories were cross-referenced to validate performance claims and identify reproducibility considerations.

Analytical methods included cross-segmentation mapping to reveal alignment between product offerings and application needs, sensitivity assessments to explore the operational impact of policy and supply chain shifts, and stakeholder impact mapping to prioritize recommendations. Rigorous quality controls-such as interview validation, source corroboration, and iterative peer review-were applied throughout the research lifecycle to maintain accuracy and practical relevance for decision-makers.

Concluding synthesis that connects technological maturity, operational resilience, and collaborative strategies to realize the value of short-read sequencing

In conclusion, short-read sequencing stands at the intersection of mature technical capability and expanding application breadth, offering a pragmatic balance between accuracy, throughput, and established analytical ecosystems. The technology's continued refinement in reagents, instrument automation, and data analysis is broadening its applicability from core research laboratories to clinical and industrial settings. Simultaneously, external forces such as regulatory evolution and tariff-driven supply chain adjustments are prompting stakeholders to adopt more resilient procurement and validation practices.

The cumulative picture is one of steady integration: vendors that deliver interoperable, validated workflows and resilient supply strategies will realize greater adoption, while customers that prioritize standardized processes and training will extract more consistent value from their investments. Strategic partnerships across manufacturers, service providers, and end users accelerate the translation of sequencing capabilities into actionable insights for diagnostics, drug discovery, and public health surveillance. By aligning technological choices with operational realities and regulatory requirements, organizations can harness short-read sequencing to advance scientific goals and clinical outcomes.

This document synthesizes the core dynamics shaping the ecosystem and outlines practical steps for stakeholders seeking to optimize technology selection, supply continuity, and application deployment in the near term and beyond.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Short-read Sequencing Market, by Product

  • 8.1. Consumables
    • 8.1.1. Flow Cells & Reagents
    • 8.1.2. Library Prep Kits
  • 8.2. Instruments
    • 8.2.1. Benchtop Sequencers
    • 8.2.2. High-Throughput Sequencers
  • 8.3. Software & Services
    • 8.3.1. Bioinformatics Services
    • 8.3.2. Data Analysis Software

9. Short-read Sequencing Market, by Technology

  • 9.1. Semiconductor Sequencing
    • 9.1.1. Ion Proton
    • 9.1.2. Ion Torrent PGM
  • 9.2. Sequencing Ligation
  • 9.3. Sequencing Synthesis

10. Short-read Sequencing Market, by End User

  • 10.1. Academic & Research Institutes
  • 10.2. Contract Research Organizations
  • 10.3. Hospitals & Diagnostic Labs
  • 10.4. Pharma & Biotech Companies

11. Short-read Sequencing Market, by Application

  • 11.1. Epigenomics
    • 11.1.1. Chromatin Accessibility Analysis
    • 11.1.2. DNA Methylation Analysis
  • 11.2. Genomics
    • 11.2.1. Resequencing
    • 11.2.2. Targeted Sequencing
    • 11.2.3. Whole Genome Sequencing
  • 11.3. Metagenomics
  • 11.4. Transcriptomics

12. Short-read Sequencing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Short-read Sequencing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Short-read Sequencing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Short-read Sequencing Market

16. China Short-read Sequencing Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. BGI Genomics Co., Ltd.
  • 17.7. Bio-Rad Laboratories, Inc.
  • 17.8. Danaher Corporation
  • 17.9. Eppendorf SE
  • 17.10. Eurofins Scientific SE
  • 17.11. F. Hoffmann-La Roche Ltd
  • 17.12. GE HealthCare Technologies Inc.
  • 17.13. Genewiz, Inc.
  • 17.14. Hamilton Company
  • 17.15. Illumina, Inc.
  • 17.16. Macrogen, Inc.
  • 17.17. Novogene Co., Ltd.
  • 17.18. Oxford Nanopore Technologies plc
  • 17.19. Pacific Biosciences of California, Inc.
  • 17.20. PerkinElmer, Inc.
  • 17.21. Psomagen, Inc.
  • 17.22. Qiagen N.V.
  • 17.23. Takara Bio Inc.
  • 17.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 196. GCC SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 197. GCC SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 199. GCC SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 201. GCC SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. GCC SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. GCC SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 229. G7 SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 230. G7 SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. G7 SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 234. G7 SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. G7 SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. G7 SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 240. NATO SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 241. NATO SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 242. NATO SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 243. NATO SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 245. NATO SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. NATO SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. NATO SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 248. NATO SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)